Shanghai Endi Biotechnology Co., Ltd
Home>Products>Ella fully automatic biomarker detection platform
Product Groups
Firm Information
  • Transaction Level
    VIP member
  • Contact
  • Phone
  • Address
    502, Building D11, Chuangyan Zhizao, Lane 3188, Xiupu Road, Pudong New Area, Shanghai
Contact Now
Ella fully automatic biomarker detection platform
Ella fully automatic biomarker detection platform
Product details

Fully automatic biomarker detection platform

The Ella platform will bring you more accurate and reliable data and simplified operation experience, improving your work efficiency. By utilizing innovative microfluidic cartridges, Ella's fully automated biomarker detection platform can quickly obtain high-quality data results and perform multi-channel synchronous detection of up to 8 biomarkers (per cartridge).

EllaPlatform features:

automation

high sensitivity

WIDE DYNAMIC RANGE

Accurate and reproducible results

Easy Method Transfer

Built in standard curve

biosafety(Applicable to P2 and P3 laboratories)/

automation

After the start of the immunoassay run,Ella will run automatically throughout the entire process without any manual intervention.

The Simple Plex cartridge will perform all reagent addition, cleaning, and incubation steps under precise control.

Microfluidic technology

Ella's immunological testing will be conducted in a microfluidic Simple Plex cartridge. The relevant antibody pairs and reagents have been pre packaged in a cartridge and rigorously validated. The cartridge is ready to use and convenient.

The card box comes with a built-in standard curve at the factory, so you don't need to create a standard curve. Before running the instrument for testing, simply add the sample and buffer solution to the cartridge. The microfluidic control circuit contains multiple nanoscale microreactors(GNR), Provide synchronous multi-point measurement. With the help of built-in standard curves, comprehensive analysis data can be obtained in less than 90 minutes

Reduce manual errors

The Ella platform eliminates the tedious setup and lengthy incubation steps in traditional board based immunoassays. The automated microfluidic cartridge design minimizes human error while ensuring highly accurate and reproducible data results between different users and laboratories.

No cross reactivity

Traditional multiple detection may result in cross reactivity and interference, thereby reducing data quality.Ella can allocate the test sample to four parallel microfluidic control channels, with a maximum of two detections within the same channel, in order to eliminate the problem of cross reaction signal interference. By utilizing flexible card box board types, you can perform multiple interference free detection on over 250 biomarkers.

a straw shows which way the wind blows

Regardless of the research field, it is crucial to obtain as much data as possible from a limited sample.

existIn the Simple Plex cartridge, only a small amount of sample is needed to provide three repeated test results, without the need for additional wells for testing.

accuracy & precision

Due to the numerous manual operation steps and the introduction of human error, traditional methods are usedThe reproducibility of data obtained from ELISA and multiplex detection platforms is highly challenging. The fully automated Ella platform eliminates these variable factors, providing excellent precision and accuracy. Ella makes it easy to transfer or expand your research to other laboratories or contract research organizations CRO. The simple process, built-in standard curves, and precise control of automation help ensure data consistency, whether in different laboratories, between different instruments, or by different operators, Ella will provide you with reliable data.

high sensitivity

Ella uses fluorescence detection, which has higher sensitivity to detect low expression abundance proteins. A wider dynamic range enables simultaneous detection of high abundance and low abundance analytes, thereby reducing the hassle of repeated runs or multiple dilutions.

Widely used

Ella can detect over 250 validated biomarkers, covering preclinical, clinical trial research, biomedical and other application fields, and is continuously expanding.

Cell and gene therapy

• Cardiovascular system

Neuroscience

• Tumor immunity

• Autoimmunity

• Biotechnology

Card box optional

Online inquiry
  • Contacts
  • Company
  • Telephone
  • Email
  • WeChat
  • Verification Code
  • Message Content

Successful operation!

Successful operation!

Successful operation!